I honestly don't think pharma is worried about CBD and don't know what to do about it. The only "pharma" company that knows much about CBD now is GW Pharma. They are the only IND-approved drug and they will fight for their turf. A really smart pharma company would try to buy CVSI (I hope they won't yet), but they wouldn't know what to do with it. What are some key not yet proven uses of CBD - addiction. You think the Purdue Pharmas of the world are going to fight tooth and nail about their wonderful product.
I think that once the regulatory pathway for supplement/food CBD is worked out, a small number of companies will dominate and CVSI will be at or near the top. They are working at all levels now, and are clearly the most proactive, strategic company. Starting with Mona II deciding wisely 6-7 years ago to get out of the MJ space and into the CBD space, this company has continued to impress. We clearly don't have the respect from a stock price perspective, but once things clear up, we will be the top dog. I loved reading the reports of FDA asking Duffy MacKay questions! He's been in DC for over 10 years, is heavily connected, and I am positive that more conversations are going out of the public eye than within in. CVSI is the most developed CBD company out there, making a profit, and forward thinking. And you don't think Tomc is working on big deals??? They mentioned convenience stores at the last concall. I'd love to see 10 packs of gummies at every 7-11 and WaWa (I'm an old Jersey boy). But I'm sure there's more, and we'll hear about it when Dowling thinks it will have the biggest bang for the buck.
I continue to say, "In Dowling, Tomc, and MacKay I trust." And I'm sure Mona III is working hard to maximize family money.
All the best.
MT
News 
Market Data 
Discover 
